Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia.
about
The association between obstructive sleep apnea and metabolic syndrome: a systematic review and meta-analysisObstructive sleep apnea and dyslipidemia: evidence and underlying mechanismObstructive sleep apnea and dyslipidemia: implications for atherosclerosisObstructive sleep apnea predicts risk of metabolic syndrome independently of obesity: a meta-analysisChronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approachRole of sleep quality in the metabolic syndromeSleep: important considerations for the prevention of cardiovascular diseaseImpact of Sleep and Circadian Disruption on Energy Balance and Diabetes: A Summary of Workshop DiscussionsEffects of various degrees of oxidative stress induced by intermittent hypoxia in rat myocardial tissuesEffect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxiaThe efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.Pathophysiology of sleep apneaSLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELSResveratrol attenuates intermittent hypoxia-induced macrophage migration to visceral white adipose tissue and insulin resistance in male mice.Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice.Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice.Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.Intermittent and sustained hypoxia induce a similar gene expression profile in human aortic endothelial cells.Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea.Metabolic consequences of high-fat diet are attenuated by suppression of HIF-1α.Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apneaEffect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis.Chronic intermittent hypoxia induces lung growth in adult mice.Intermittent hypoxemia and OSA: implications for comorbidities.Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomesObstructive sleep apnea: an emerging risk factor for atherosclerosis.Uncoupling protein-2 mRNA expression in mice subjected to intermittent hypoxia.Continuous positive airway pressure treatment: effect on serum lipids in patients with obstructive sleep apnoea.Intermittent hypoxia exacerbates metabolic effects of diet-induced obesityIntermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea.Glucoregulatory consequences and cardiorespiratory parameters in rats exposed to chronic-intermittent hypoxia: effects of the duration of exposure and losartan.Cardiac response to chronic intermittent hypoxia with a transition from adaptation to maladaptation: the role of hydrogen peroxide.Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice.Sleep, sleep-disordered breathing and lipid homeostasis: translational evidence from murine models and childrenObstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target?2,3-Oxidosqualene cyclase protects liver cells from the injury of intermittent hypoxia by regulating lipid metabolism.Chronic intermittent hypoxia induces atherosclerosisAdverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activityPathobiology of obstructive sleep apnea-related dyslipidemia: focus on the liver.Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children.
P2860
Q26782667-CDBFFE93-3507-403B-851A-FA2F38392D87Q26999248-5258E73F-3FAF-4CFB-9294-ACF43868DE15Q27693900-80D7769E-2C01-48B7-AF42-DF585B012940Q28072758-59BB596C-D16C-4DE1-9A57-5E3C448D3DC9Q28076146-04B67CB8-4AA7-48FF-9258-A428C6602CE3Q28076751-0447DA75-D9D1-4970-851A-1B9ED5813E44Q28391278-49308E00-459D-46DF-A88D-789F77D0626EQ28395423-67F4D112-7D0B-437F-9FBD-8706E54669DDQ28574385-0151E579-4DC6-481F-A508-53D94307F3C7Q28588503-2CFC17E7-AE29-4271-8A77-4083E8B894F9Q30428971-1F6DAB5F-D77D-4597-905D-3963F9C56D12Q30440658-32E41367-BE2D-4630-8A3E-7743F3C790EEQ30494316-DA71605B-6B94-4AC8-B960-74CAC857DBEBQ33569634-4278AB40-6EF5-4632-BE1F-CE4F3D721FACQ33756050-0E005879-8512-4A33-AE75-AE95CC656CB6Q33781383-39DF71D5-AE85-4240-9E41-0B06280D4625Q33802207-D895EF5A-4B47-4B89-B4B2-44B4DEFF2F87Q33847657-5DD93BBD-0641-4BEE-8CB7-D8AA0B9CFBD6Q33916216-C6881CBC-D280-417E-A2AA-02F69A9F7755Q34437691-2F7565E4-55B5-4E77-904D-26E8E76644EEQ34447691-3FC455F1-CF5D-4B16-B518-502786E9E5E5Q34542904-AC10C71A-109E-43EE-AAEE-77E9783FC2D7Q34598840-D3492C50-221A-431F-94D6-F6F657E65623Q34840423-8CADEDB0-E578-4DCC-B78F-94B1BA6A90F5Q35217599-906C4B3C-B74B-44C3-974B-707A4079E89CQ35410946-D98C77D2-A528-4C97-A15C-8EA18549E459Q35597819-406C9F7B-A106-4603-BEDB-27B1C73D16F0Q35646020-5BAA62FD-DEB0-4F29-986C-B56C4D03981BQ35702905-0F35C6CA-E05B-4BC6-9F85-5160B45E1CE3Q35830163-61118464-F435-4C84-9C35-4E3D58A3C3FEQ35875682-93E76A97-0819-4800-BE6E-E182D5048909Q35998141-34AF1540-0D78-40DD-9B20-367AAD3B1F46Q36175990-8AB8FDF0-212F-4788-A052-73BB7A407464Q36199242-32E77E78-2CA3-4C4A-B97C-AD0A87513BBBQ36323458-428D20A6-8FBC-4332-AE98-4084006D7B5DQ36327858-CE102B57-C0D6-42A2-BFB6-C046B2BB62A8Q36330538-1B52993E-A1E7-48EC-A155-DA9BFF196349Q36525556-ADACF602-202C-43F4-B169-E0C63E57A007Q36546481-26DD5C7D-F862-4027-B323-73EFF6141094Q36657681-841C64A3-C2FC-46B6-BAA2-8F6456F2BB6C
P2860
Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Hyperlipidemia and lipid perox ...... chronic intermittent hypoxia.
@en
Hyperlipidemia and lipid perox ...... chronic intermittent hypoxia.
@nl
type
label
Hyperlipidemia and lipid perox ...... chronic intermittent hypoxia.
@en
Hyperlipidemia and lipid perox ...... chronic intermittent hypoxia.
@nl
prefLabel
Hyperlipidemia and lipid perox ...... chronic intermittent hypoxia.
@en
Hyperlipidemia and lipid perox ...... chronic intermittent hypoxia.
@nl
P2093
P2860
P1476
Hyperlipidemia and lipid perox ...... chronic intermittent hypoxia.
@en
P2093
Ashika Nanayakkara
Christopher P O'Donnell
Jianguo Li
Philip L Smith
Vladimir Savransky
Vsevolod Y Polotsky
P2860
P304
P356
10.1152/JAPPLPHYSIOL.01081.2006
P407
P577
2006-11-02T00:00:00Z